Semler Scientific (NASDAQ:SMLR - Get Free Report) was upgraded by equities researchers at Maxim Group to a "strong-buy" rating in a research report issued on Wednesday, Marketbeat Ratings reports. The brokerage presently has a $95.00 price objective on the stock. Maxim Group's price objective would suggest a potential upside of 106.23% from the company's current price.
A number of other brokerages also recently commented on SMLR. Benchmark assumed coverage on shares of Semler Scientific in a research report on Tuesday. They set a "buy" rating and a $101.00 price objective on the stock. Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd.
Get Our Latest Report on Semler Scientific
Semler Scientific Price Performance
Shares of SMLR traded up $3.74 during mid-day trading on Wednesday, hitting $46.06. The company's stock had a trading volume of 293,193 shares, compared to its average volume of 560,369. The firm has a 50-day moving average price of $37.03 and a 200 day moving average price of $42.35. The stock has a market capitalization of $513.71 million, a price-to-earnings ratio of -17.74 and a beta of 1.39. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. Semler Scientific has a fifty-two week low of $21.77 and a fifty-two week high of $81.56.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($0.76) EPS for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%. The firm had revenue of $8.84 million during the quarter.
Institutional Trading of Semler Scientific
A number of institutional investors and hedge funds have recently modified their holdings of the stock. BNP Paribas Financial Markets bought a new stake in Semler Scientific during the 4th quarter worth approximately $30,000. Summit Securities Group LLC bought a new position in shares of Semler Scientific in the first quarter valued at $32,000. Jones Financial Companies Lllp bought a new position in shares of Semler Scientific in the fourth quarter valued at $34,000. SBI Securities Co. Ltd. boosted its position in Semler Scientific by 161.3% during the first quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock worth $35,000 after purchasing an additional 592 shares during the period. Finally, Larson Financial Group LLC bought a new position in Semler Scientific during the fourth quarter worth $38,000. 49.37% of the stock is owned by institutional investors.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
